Intrabio | ANPDF

Community News and Events

Welcome to the ANPDF blog, where we share the latest updates, stories, and breakthroughs in the fight against Niemann-Pick Disease. Join us as we raise awareness, support families, and drive research forward.

Jump to the NP-C Corner by Ellie

Search for an article or browse by topic below.

Search

Second treatment approved by FDA for Niemann-Pick disease, type C: Introducing AQNEURSA

ANPDF

Sep 254 min read

Second treatment approved by FDA for Niemann-Pick disease, type C: Introducing AQNEURSA

FDA approval of AQNEURSA offers new hope for Australian families with Niemann-Pick disease, promising better treatment and quality of life.

94 views

ANPDF

Mar 271 min read

IntraBio Media Release | March 26, 2024

IntraBio Announces U.S. FDA Accepts New Drug Application for IB1001 for the Treatment of Niemann-Pick disease type C Read the full...

31 views

IntraBio Media Release | February 7, 2024

ANPDF

Feb 81 min read

IntraBio Media Release | February 7, 2024

The New England Journal of Medicine has published a "Science behind the study" editorial on IB1001 Read the full announcement from...

24 views

ANPDF

Feb 31 min read

IntraBio Media Release | February 7, 2024

The New England Journal of Medicine has published the detailed results of the IB1001-301 Phase 3, Pivotal study with N-acetyl-L-leucine...

40 views

IntraBio Community Update | February 1, 2024

ANPDF

Feb 11 min read

IntraBio Community Update | February 1, 2024

New Drug Application for IB1001 for the treatment of NP-C disease was submitted to the US FDA in January 2024 Read the full statement...

50 views

ANPDF

Jun 29, 20231 min read

Intrabio Media Release | June 29, 2023

"IntraBio Announces Positive Pivotal Trial Results of IB1001 for the Treatment of Niemann-Pick Disease Type C" Read the full article...

47 views

Intrabio Media Release | December 5, 2022

ANPDF

Dec 6, 20221 min read

Intrabio Media Release | December 5, 2022

"IntraBio Ltd. is pleased to confirm that it has completed recruitment for its Pivotal Trial, Effects of N-Acetyl-L-Leucine on...

32 views

Community News and Events

Topics

About